BioSpace News Archive

Neuronetics, Inc. announced the granting of inducement awards of Restricted Stock Units representing a total of 27,000 shares of the Company’s common stock to five new non-executive employees.

Jasper Therapeutics, Inc. announced that, as an inducement material to entering into employment with Jasper, between August 1 2023 and August 4, 2023, five new employees were awarded options to purchase an aggregate of 555,000 shares of Jasper’s voting common stock.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Aptevo Therapeutics Inc. announced the closing of its previously announced public offering of 2,221,550 shares of common stock at a purchase price of $0.62 per share, Pre-Funded Warrants to purchase up to an aggregate of 5,842,967 shares of common stock at a purchase price of $0.619 per Pre-Funded Warrant.

The U.S. Food and Drug Administration approved Zurzuvae, the first oral medication indicated to treat postpartum depression in adults.

Insmed Incorporated today announced the granting of inducement awards to 46 new employees.

PharmaEssentia today announced the publication of a cost-effectiveness analysis of ropeginterferon alfa-2b-njft (marketed as BESREMi®) in the Journal of Comparative Effectiveness Research.

Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter ended June 30, 2023, on Wednesday, August 9, 2023, before the market opens.